Q4 2022 Memorandum

Sanofi releases Q4 2022 Memorandum for investors to use in financial modeling

(PRESS RELEASE) PARIS, 4-Jan-2023 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced…

1 year ago